This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Changwon Kho: Innovator in SUMO Activators
Introduction
Changwon Kho is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine through his innovative research and patents. With a total of 2 patents, Kho's work focuses on enhancing SUMOylation processes, which have important implications for various diseases.
Latest Patents
Kho's latest patents include the development of benzothiazole or benzoxazole compounds as SUMO activators. These compounds are designed to enhance the SUMOylation of SERCA2a, which is crucial for the treatment of heart failure, cardiovascular diseases, cancer, neurodegenerative disorders, viral infections, bacterial infections, liver disease, inflammation, and other diseases. His research aims to provide new therapeutic options for these serious health conditions.
Career Highlights
Kho is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Some of Kho's coworkers include Russell Dahl and Ah Young Lee, who contribute to his research efforts and collaborative projects.
Conclusion
Changwon Kho's contributions to the field of medicine through his patents and research highlight his role as an important innovator. His work on SUMO activators has the potential to impact the treatment of various diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile